NSRX insider transaction filings
Nasus Pharma Ltd — 4 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-29. Screen NSRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Teleman Dan Benjamin — Chief Executive Officer, Director | Holdings only — no transactions reported | EDGAR |
| 2026-06-22 | 4 | Teleman Dan Benjamin — Chief Executive Officer, Director | Purchase (P): 6,550 @ $3.10 | EDGAR |
| 2026-04-22 | 4 | Teleman Dan Benjamin — Chief Executive Officer, Director | Purchase (P): 2,900 @ $3.76 | EDGAR |
| 2026-04-01 | 4 | Teleman Dan Benjamin — Chief Executive Officer, Director | Purchase (P): 15,000 @ $2.04 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NSRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →